Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
Optimization of a screening lead for factor VIIa/TF. [electronic resource] by
- Young, W B
- Kolesnikov, A
- Rai, R
- Sprengeler, P A
- Leahy, E M
- Shrader, W D
- Sangalang, J
- Burgess-Henry, J
- Spencer, J
- Elrod, K
- Cregar, L
Producer: 20020103
In:
Bioorganic & medicinal chemistry letters vol. 11
Availability: No items available.
|
|
11.
|
Development of potent and selective factor Xa inhibitors. [electronic resource] by
- Rai, R
- Kolesnikov, A
- Li, Y
- Young, W B
- Leahy, E
- Sprengeler, P A
- Verner, E
- Shrader, W D
- Burgess-Henry, J
- Sangalang, J C
- Allen, D
- Chen, X
- Katz, B A
- Luong, C
- Elrod, K
- Cregar, L
Producer: 20010927
In:
Bioorganic & medicinal chemistry letters vol. 11
Availability: No items available.
|
|
12.
|
Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa. [electronic resource] by
- Verner, E
- Katz, B A
- Spencer, J R
- Allen, D
- Hataye, J
- Hruzewicz, W
- Hui, H C
- Kolesnikov, A
- Li, Y
- Luong, C
- Martelli, A
- Radika, K
- Rai, R
- She, M
- Shrader, W
- Sprengeler, P A
- Trapp, S
- Wang, J
- Young, W B
- Mackman, R L
Producer: 20010906
In:
Journal of medicinal chemistry vol. 44
Availability: No items available.
|